EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ovarian microenvironment remodeling in premature ovarian insufficiency: From hormone replacement to regenerative strategies with mesenchymal stem cells and exosomes

Mingxia Feng, Jiamin Su, Guangjiao Yu, Juanling Wu, Ying Li, Li Yang, Tongtong Liang, Lei Yu, Zhaoyang Zeng, Fenqin Zhao

Journal of Reproductive Immunology · 2026

DOI: 10.1016/j.jri.2026.104959 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Reproductive Immunology, 2026. Verfasst von Mingxia Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Gansu University of Chinese Medicine, Lanzhou, Gansu Province 730000, China. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Mesenchymal Stem Cells, Exosomes, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 77 Literaturangaben. Gefördert von: Natural Science Foundation of Gansu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature ovarian insufficiency (POI) is a heterogeneous disorder characterized by loss of ovarian function before age 40, causing infertility, hypoestrogenism-related complications, and significantly impaired quality of life. Although hormone replacement therapy (HRT) remains the standard treatment for symptom relief and long-term health protection, it cannot restore ovarian reserve or natural fertility. This review summarizes the etiology and pathogenesis of POI, emphasizing mitochondrial dysfunction, oxidative stress, chronic inflammation, and progressive deterioration of the ovarian microenvironment. We critically evaluate the strengths and limitations of conventional HRT based on the latest 2024 international evidence-based guidelines, and comprehensively overview emerging regenerative therapies, focusing on mesenchymal stem cells (MSCs) and MSC-derived small extracellular vesicles (sEVs). MSCs exert therapeutic effects mainly through paracrine actions, including anti-apoptotic, anti-inflammatory, and pro-angiogenic activities. MSC-sEVs, particularly hypoxia-preconditioned ones, offer a safer cell-free alternative. They protect mitochondrial function via the SIRT3/PGC-1α pathway and other related mechanisms such as Nrf2/Keap1 and AMPK signaling. Current clinical evidence for both approaches remains preliminary, consisting mainly of small-scale trials with heterogeneous protocols and short follow-up. We propose an innovative ovarian microenvironment remodeling framework that integrates symptomatic HRT with etiology-targeted regenerative interventions using MSCs or engineered sEVs. In summary, while HRT forms the foundation of POI management, MSC-sEVs represent a highly promising cell-free platform that may shift the paradigm from hormone replacement to functional regeneration, restoring both endocrine function and fertility in POI patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Ovarian InsufficiencyMesenchymal Stem CellsExosomesMesenchymal Stem Cell TransplantationOvaryHormone Replacement TherapyFemaleHumansAnimalsCellular MicroenvironmentRegeneration

Stichwörter der Autor:innen

Hormone replacement therapyMesenchymal stem cellsMitochondrial dysfunctionOvarian microenvironmentPremature ovarian insufficiencyRegenerative medicineSEVs

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Gansu University of Chinese Medicine, Lanzhou, Gansu Province 730000, China.
  • Department of Obstetrics and Gynecology, Lanzhou Maternal and Child Health Care Hospital, Lanzhou, Gansu Province, China.
  • Department of Surgery, Gansu University of Chinese Medicine, Lanzhou, Gansu Province 730000, China.
  • Department of Obstetrics and Gynecology, Gansu University of Chinese Medicine, Lanzhou, Gansu Province 730000, China. Electronic address: zfq_china@163.com.

Förderung

  • Natural Science Foundation of Gansu Province
  • National Natural Science Foundation of China

Zitieren

APA

Feng, M., Su, J., Yu, G., Wu, J., Li, Y., Yang, L., Liang, T., Yu, L., Zeng, Z., & Zhao, F. (2026). Ovarian microenvironment remodeling in premature ovarian insufficiency: From hormone replacement to regenerative strategies with mesenchymal stem cells and exosomes. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2026.104959

Vancouver

Feng M, Su J, Yu G, Wu J, Li Y, Yang L, et al. Ovarian microenvironment remodeling in premature ovarian insufficiency: From hormone replacement to regenerative strategies with mesenchymal stem cells and exosomes. Journal of Reproductive Immunology. 2026. doi:10.1016/j.jri.2026.104959

BibTeX
@article{Feng2026,
  author = {Feng, Mingxia and Su, Jiamin and Yu, Guangjiao and Wu, Juanling and Li, Ying and Yang, Li and Liang, Tongtong and Yu, Lei and Zeng, Zhaoyang and Zhao, Fenqin},
  title = {Ovarian microenvironment remodeling in premature ovarian insufficiency: From hormone replacement to regenerative strategies with mesenchymal stem cells and exosomes},
  journal = {Journal of Reproductive Immunology},
  year = {2026},
  doi = {10.1016/j.jri.2026.104959}
}
Kostenlos starten →